Buzzakoo Buzzakoo
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Reels
  • Blogs
  • Offers
  • Jobs
  • Forums
  • Movies
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Riyaj Straits a adăugat un sunet Alte
    2025-09-04 08:09:15 -
    Biosimilar Monoclonal Antibodies Market Report Backed by Credible Industry Expertise
    Biosimilar Monoclonal Antibodies Market Trends, Forecast, and Growth The global biosimilar monoclonal antibodies market size was valued at USD 14.92 Billion in 2024 and is projected to grow from USD 17.35 Billion in 2025 to reach USD 58.07 Billion by 2033, exhibiting a CAGR of 16.3% during the forecast period (2025–2033). as reported by Straits...
    0 Commentarii 0 Distribuiri 983 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Emma Verghise
    a adăugat un sunet Alte
    2025-11-27 13:31:39 -
    Increasing Demand for High-Quality Antibodies Strengthens Global Market Performance Across Life Sciences and Diagnostic Applications
    The global research antibodies market was valued at USD 1.72 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% through 2034. This robust expansion is underpinned by escalating global investment in basic and translational life sciences research, yet regional trajectories diverge significantly due to disparities in funding ecosystems, regulatory stringency,...
    0 Commentarii 0 Distribuiri 49 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Sonu Pawar a adăugat un sunet Wellness
    2025-12-02 15:55:29 -
    Precision Engineering and Biosimilar Competition: Core Antibodies Market Strategy
    The core Antibodies Market Strategy for leading players is a defensive and offensive push centered on innovation and cost-effectiveness: Offensive Innovation: The primary strategy is accelerating the development of Next-Generation Antibody formats (Bispecifics, ADCs, Nanobodies) to achieve enhanced therapeutic efficacy through dual targeting and precise payload delivery, minimizing systemic...
    0 Commentarii 0 Distribuiri 24 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2025 Buzzakoo Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Contacteaza-ne Director